Bassler Bonnie L
SEC insider (Form 3/4/5 filer). CIK 0001683607. Director at Royalty Pharma plc (RPRX) and 2 other issuers. 19 reported Form 4/5 transactions since Sep 2024; latest on Sep 30, 2026. Located in NEW YORK, NY.
Companies Bassler Bonnie L has filed insider reports for
- Royalty Pharma plc (RPRX): Director
- REGENERON PHARMACEUTICALS, INC. (REGN): Director
- Cidara Therapeutics, Inc. (CDTX): Director
Bassler Bonnie L
CIK: 0001683607
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (19 total)
- Sep 30, 2026RPRX
Royalty Pharma plc
AwardDirect642 shares at avg. $58.41$37K - Jun 30, 2026RPRX
Royalty Pharma plc
AwardDirect689 shares at avg. $54.40$37K - Jun 5, 2026RPRX
Royalty Pharma plc
AwardDirect4.5K shares- - Jan 7, 2026REGN
REGENERON PHARMACEUTICALS, INC.
ExerciseDirect1.5K shares at avg. $374.12$561K - Jan 7, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect1.5K shares at avg. $800.00$1.2M - Jan 7, 2026CDTX
Cidara Therapeutics, Inc.
DispositionDirect15 shares at avg. $221.50$3K - Jan 2, 2026REGN
REGENERON PHARMACEUTICALS, INC.
AwardDirect155 shares- - Dec 31, 2025RPRX
Royalty Pharma plc
AwardDirect967 shares at avg. $38.74$37K - Nov 20, 2025REGN
REGENERON PHARMACEUTICALS, INC.
ExerciseDirect760 shares at avg. $371.40$282K - Nov 20, 2025REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect760 shares at avg. $750.00$570K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 30, 2026 |  RPRX Royalty Pharma plc | Award | 642 | $58.41 | $37,496 | Direct |
| Jun 30, 2026 | RPRX Royalty Pharma plc | Award | 689 | $54.40 | $37,481 | Direct |
| Jun 5, 2026 | RPRX Royalty Pharma plc | Award | 4,545 | - | $0 | Direct |
| Jan 7, 2026 |  REGN REGENERON PHARMACEUTICALS, INC. | Exercise | 1,500 | $374.12 | $561,180 | Direct |
| Jan 7, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 1,500 | $800.00 | $1,200,000 | Direct |
| Jan 7, 2026 |  CDTX Cidara Therapeutics, Inc. | Disposition | 15 | $221.50 | $3,323 | Direct |
| Jan 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Award | 155 | - | $0 | Direct |
| Dec 31, 2025 | RPRX Royalty Pharma plc | Award | 967 | $38.74 | $37,463 | Direct |
| Nov 20, 2025 | REGN REGENERON PHARMACEUTICALS, INC. | Exercise | 760 | $371.40 | $282,264 | Direct |
| Nov 20, 2025 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 760 | $750.00 | $570,000 | Direct |
1-10 of 19 transactions